Boutique MedTech CRO gains access to unified eClinical platform with wholesale pricing, training, and joint marketing ...

A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

Amgen (NASDAQ:AMGN) today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to ...

Semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease regardless of baseline adiposity. Cardiovascular benefit was largely ...

NIH halts arm of clinical trial evaluating a potential stroke treatment: Bethesda, Maryland Thursday, February 12, 2026, 18:00 Hrs [IST] The National Institutes of Health (NIH) ha ...

Excess body weight may help explain why some chronic illnesses frequently occur together, according to a study.

TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...

CORALreef Lipids randomized 2,909 adults (2:1) to enlicitide 20 mg daily or placebo across 168 sites, using stratification by renal function, baseline statin use, and region. LDL-C at week 24 ...

Neurocrine Biosciences, Inc. ( NBIX) Q4 2025 Earnings Call February 11, 2026 4:30 PM EST ...

Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...

FDA clearance covers pembrolizumab plus paclitaxel ± bevacizumab for PD-L1 CPS ≥1 platinum-resistant disease after one or two prior systemic regimens, introducing PD-1 inhibition into this treatment ...

The Rapid RCT Lab is a nationally-leading team conducting innovative, rapid RCTs to improve the delivery of services at the ...